Treatment Options for EGFR-positive Lung Cancer

Case #3: Patient with EGFR Exon 21 L858R Alteration NSCLC- 2024 Case Based Panel DiscussionsПодробнее

Case #3: Patient with EGFR Exon 21 L858R Alteration NSCLC- 2024 Case Based Panel Discussions

Evaluating first-line therapies for EGFR-mutated NSCLC in 2024Подробнее

Evaluating first-line therapies for EGFR-mutated NSCLC in 2024

Navigating Rapid Changes in First- and Later-Line Treatment of EGFR-Mutated NSCLCПодробнее

Navigating Rapid Changes in First- and Later-Line Treatment of EGFR-Mutated NSCLC

Is osimertinib the standard of care in resected EGFR mutation positive early stage NSCLC?Подробнее

Is osimertinib the standard of care in resected EGFR mutation positive early stage NSCLC?

Christi - What has your treatment experience been for your EGFR-positive lung cancer?Подробнее

Christi - What has your treatment experience been for your EGFR-positive lung cancer?

Understanding NSCLC Treatment When You Have an EGFR MutationПодробнее

Understanding NSCLC Treatment When You Have an EGFR Mutation

Novel Therapies for EGFR Exon 20 Insertions and ALK-Positive NSCLC: Developments and ImplicationsПодробнее

Novel Therapies for EGFR Exon 20 Insertions and ALK-Positive NSCLC: Developments and Implications

CRSF 07th Masterclass: Uncommon EGFR Mutations in Lung Cancer | Dr. Pradeep VentrapatiПодробнее

CRSF 07th Masterclass: Uncommon EGFR Mutations in Lung Cancer | Dr. Pradeep Ventrapati

EGFR Lung UpdatesПодробнее

EGFR Lung Updates

CRSF 07th Masterclass: Post-Osimertinib Options in EGFR Mutated Lung Cancer | Dr. Somnath RoyПодробнее

CRSF 07th Masterclass: Post-Osimertinib Options in EGFR Mutated Lung Cancer | Dr. Somnath Roy

Continued use of osimertinib reduces CNS metastasis in EGFR mutant lung cancerПодробнее

Continued use of osimertinib reduces CNS metastasis in EGFR mutant lung cancer

EGFR positive stage 4 Lung cancer | Liquid Biopsy | A true success story | Dr. Chandrakanth M.VПодробнее

EGFR positive stage 4 Lung cancer | Liquid Biopsy | A true success story | Dr. Chandrakanth M.V

Gefitinib: Targeted Treatment for EGFR Mutation-Positive Lung Cancer | GlpBioПодробнее

Gefitinib: Targeted Treatment for EGFR Mutation-Positive Lung Cancer | GlpBio

What every EGFR patient needs to knowПодробнее

What every EGFR patient needs to know

How do doctors treat lung cancer with EGFR mutations?Подробнее

How do doctors treat lung cancer with EGFR mutations?

Future Research and Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient ForumПодробнее

Future Research and Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum

First line treatment options for activating EGFR non-small cell lung Cancer | Dr. Alexander SpiraПодробнее

First line treatment options for activating EGFR non-small cell lung Cancer | Dr. Alexander Spira

Targeted Therapy for Non-Small Cell Lung Cancer with an EGFR Exon 20 InsertionПодробнее

Targeted Therapy for Non-Small Cell Lung Cancer with an EGFR Exon 20 Insertion

EGFR Mutations in Advanced NSCLC - Targeted Therapies in Lung Cancer 2023Подробнее

EGFR Mutations in Advanced NSCLC - Targeted Therapies in Lung Cancer 2023

A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLCПодробнее

A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLC